Zobrazeno 1 - 10
of 582
pro vyhledávání: '"Suresh T Chari"'
Autor:
Santanu Bhattacharya, Krishnendu Pal, Anil K Sharma, Shamit K Dutta, Julie S Lau, Irene K Yan, Enfeng Wang, Ahmed Elkhanany, Khalid M Alkharfy, Arunik Sanyal, Tushar C Patel, Suresh T Chari, Mark R Spaller, Debabrata Mukhopadhyay
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114409 (2014)
GAIP interacting protein C terminus (GIPC) is known to play an important role in a variety of physiological and disease states. In the present study, we have identified a novel role for GIPC as a master regulator of autophagy and the exocytotic pathw
Externí odkaz:
https://doaj.org/article/09280cc855094a579ee67ad2cb4917df
Autor:
Anusha Shirwaikar Thomas, Michael Abreo, Ahmed Sayed Ahmed, Sai Prasada Rao Manikonda, Mostafa Eyada, Aaron Issac, Fiyinfoluwa Abraham, Jake Sheraj Jacob, Yinghong Wang, Sireesha Yedururi, Suresh T. Chari
Publikováno v:
Gastro Hep Advances, Vol 3, Iss 3, Pp 361-367 (2024)
Background and Aims: Immune checkpoint inhibitor therapy causes numerous immune-related adverse events, including autoimmune pancreatic injury (AIPI), which results in rapid organ atrophy. We profiled the clinico-radiological features, short-term nat
Externí odkaz:
https://doaj.org/article/9f78a5fcb47042058e02ced35c78089a
Autor:
J. de la Fuente, Jacob Lui, Ryan J. Lennon, Arjun Chatterjee, Rondell P. Graham, Lizhi Zhang, Michael L. Kendrick, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, David M. Nagorney, Ferga C. Gleeson, Michael J. Levy, Vinay Chandrasekhara, Randall K. Pearson, Bret T. Petersen, Santhi S. Vege, Suresh T. Chari, Shounak Majumder
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 6, Pp 1099-1107 (2022)
Background and Aims: Management of intraductal papillary mucinous neoplasms (IPMNs) relies on clinical and imaging features to select patients for either pancreatectomy or periodic image-based surveillance. We aimed to compare outcomes in patients wi
Externí odkaz:
https://doaj.org/article/73732cb052454c85af675fdb9d34e2bd
Autor:
Yasuki Hori, MD, Suresh T. Chari, MD, Yoshihisa Tsuji, MD, PhD, Naoki Takahashi, MD, Dai Inoue, MD, Phil A. Hart, MD, Takeshi Uehara, MD, Masayasu Horibe, MD, Satoshi Yamamoto, MD, Akira Satou, MD, Lizhi Zhang, MD, Kenji Notohara, MD, Itaru Naitoh, MD, Takahiro Nakazawa, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 535-541 (2021)
Biliary strictures caused by inflammation or fibrosis lead to jaundice and cholangitis which often make it difficult to distinguish malignant strictures. In cases when malignancy cannot be excluded, surgery is often performed. The concept of immunogl
Externí odkaz:
https://doaj.org/article/d49c760554e049a2aa3baef15db5551b
Autor:
Tejeshwar Jain, Prateek Sharma, Bhuwan Giri, Srikanth Iyer, Vrishketan Sethi, Ejas P. Bava, Utpreksha Vaish, Preeti Sahay, Jashodeep Datta, Sushanth Reddy, John Bart Rose, Anam Khan, Nipun Merchant, Suresh T. Chari, Vikas Dudeja
Publikováno v:
HPB. 24:1729-1737
Exocrine pancreatic insufficiency (EPI) is frequently seen in patients with pancreatic cancer (PDAC) and is thought to contribute to nutritional complications. While EPI can be pharmacologically temporized with pancreatic enzyme replacement therapy (
Autor:
Sovanlal Mukherjee, Panagiotis Korfiatis, Hala Khasawneh, Naveen Rajamohan, Anurima Patra, Garima Suman, Aparna Singh, Jay Thakkar, Nandakumar G. Patnam, Kamaxi H. Trivedi, Aashna Karbhari, Suresh T. Chari, Mark J. Truty, Thorvardur R. Halfdanarson, Candice W. Bolan, Kumar Sandrasegaran, Shounak Majumder, Ajit H. Goenka
Publikováno v:
Pancreatology.
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplemental Figure 3 shows the distributions in plasma from controls and PDAC patients by stage of disease and standardized copy numbers of all MDMs other than HOXA1 and PRKCB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a717d799158338ead95fc1b4cf073db
https://doi.org/10.1158/1078-0432.22483674
https://doi.org/10.1158/1078-0432.22483674
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Supplementary Tables and Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2910971755fc70ffb556e609909e8e
https://doi.org/10.1158/1078-0432.22483671
https://doi.org/10.1158/1078-0432.22483671
Autor:
John B. Kisiel, David A. Ahlquist, Suresh T. Chari, Gloria M. Petersen, Hatim T. Allawi, Graham P. Lidgard, Karen A. Doering, Jaime de la Fuente, Neil Postier, Kelli N. Burger, William R. Bamlet, Douglas W. Mahoney, Chung Wah Wu, Calise K. Berger, Patrick H. Foote, William R. Taylor, Shounak Majumder
Purpose:We have previously identified tissue methylated DNA markers (MDMs) associated with pancreatic ductal adenocarcinoma (PDAC). In this case–control study, we aimed to assess the diagnostic performance of plasma MDMs for PDAC.Experimental Desig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfe6d10f173d139a456cd7a066ad01c
https://doi.org/10.1158/1078-0432.c.6531204.v1
https://doi.org/10.1158/1078-0432.c.6531204.v1
Autor:
Debabrata Mukhopadhyay, Suresh T. Chari, Randal J. Kaufman, Gloria M. Petersen, Mark Truty, Santanu Bhattacharya, Julie S. Lau, Thomas C. Smyrk, Shamit K. Dutta, Gunisha Sagar, Naureen Javeed
Supplementary Table 1. Pharmacological Inhibitors of Endocytic Pathways
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c94a7265494754653577ee73cfa65cd
https://doi.org/10.1158/1078-0432.22459881
https://doi.org/10.1158/1078-0432.22459881